Title	Publication Date	Language	Citations
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China	2020/06/01	English	4,495
Amyloid-β and Tau	2014/04/01	English	1,206
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs	2018/03/01	English	791
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019	2020/08/01	English	639
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease	2017/05/01	English	593
Inflammation and Neuroprotection in Traumatic Brain Injury	2015/03/01	English	538
The Parkinson Pandemic—A Call to Action	2018/01/01	English	500
The Preclinical Alzheimer Cognitive Composite	2014/08/01	English	464
Sleep Quality and Preclinical Alzheimer Disease	2013/05/01	English	459
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease	2019/08/01	English	454
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease	2013/09/01	English	452
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies	2014/03/01	English	422
Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population	2019/05/01	English	410
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology	2019/09/01	English	409
Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders	2018/09/01	English	406
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza	2020/11/01	English	391
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease	2017/10/01	English	385
New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression	2015/08/01	English	384
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease	2019/07/01	English	380
Evaluation of Galcanezumab for the Prevention of Episodic Migraine	2018/09/01	English	380
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort	2017/10/01	English	368
Association of Proton Pump Inhibitors With Risk of Dementia	2016/04/01	English	362
Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury	2019/01/01	English	360
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy	2016/11/01	English	345
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis	2020/09/01	English	334
Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease	2016/11/01	English	330
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression	2014/03/01	English	327
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression	2016/01/01	English	322
Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains	2017/01/01	English	314
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies	2020/02/01	English	312